Sadia Z. Shah, M.D.

Dr. Shah is a Consultant Lung Transplant Pulmonologist and Critical Care specialist at Mayo Clinic, Florida, specializing in taking care of patients with end-stage lung disease, Lung Transplant and Larynx-Trachea Transplant. She served as the Medical Director for Larynx-Trachea Transplant Program and Interim Medical Director for the Lung Transplant Program at Mayo Clinic, Arizona.

Dr. Shah completed her Fellowship in Heart-Lung and Lung Transplant from Stanford University. She is Board Certified in Pulmonary and Critical Care Medicine and has specialized in Lung Transplant medicine. She is Fellow at College of Chest Physicians and is an MBA from Isenberg School of Management, University of Massachusetts. Dr. Shah has been recognized as an esteemed educator and serves as a faculty at Mayo Clinic Alix School of Medicine at Arizona Campus.

Her exemplary work has earned her recognition as a Top Doctor in 2022. She has served in numerous leadership and advisory roles, including as a Member of the Mayo Clinic/Google Advisory Board, the Mayo Clinic 2030 Disruptive Innovation Committee, the Mayo Pharmaceutical Formulary Committee, and the Florida Clinical Practice Quality Oversight Subcommittee.

Dr. Shah is an active member of the International Society of Heart and Lung Transplantation and the American Transplant Congress. Additionally, she is an integral part of the Mayo Clinic Transplant Convergence Group, which fosters collaboration among the Arizona, Minnesota, and Florida Transplant Divisions. This group ensures that all Mayo Clinic sites consistently deliver the most advanced and highest quality care to lung transplant patients.

Significance to Patient Care

Her research focuses on Interstitial Lung Disease, Lung Transplant and Larynx-Trachea Transplant.

Focus areas

• Lung Transplant: Specific areas of interest include Lung Transplant acute cellular rejection, Antibody mediated rejection, Bronchiolitis Obliterans, Lung Transplant infection. Dr. Shah collaborates with Division of Cardiothoracic Surgery for management of Lung Transplant patients.
• Larynx-Trachea Transplant: Dr. Shah is interested in Vascularized Composite Allo-transplantation and has been collaborating with Division of Ear, Nose and Throat to start the first Larynx-Trachea Transplant Program in Mayo Clinic, Arizona. She is recipient of MEGA Award: Tracheal Replacement Using Bioengineered 3-D-Printed Tracheal Scaffold with Amniotic Membrane Inlay Graft.
• Interstitial Lung Disease: Dr. Shah is interested in Pulmonary Fibrosis, Interstitial Lung Disease secondary to connective tissue disease and Hypersensitivity Pneumonitis. She believes in team approach for management of these critically sick patients and collaborates with Division of Rheumatology, Interventional Pulmonary and Cardiothoracic Surgery to provide them the optimal care.